CCND1 and neoplasm: Another 16% showed significant amplifications or increases in mRNA expression of CDK4, CDK6, and/or Cyclin D1 expression; both these classes of mutations would contribute to an aberrantly overactive cell cycle and, presumably, tumor growth.